DAFNA Capital Management LLC
Position in AUTL — Autolus Therapeutics plc
CIK 1389933
LOS ANGELES, CA
Position in AUTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$286,905
+$39,449 QoQ
Shares Held
179,316
0.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#28
of 84 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. AUTL ranks #60 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in AUTL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,905 | 179,316 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $247,456 | 179,316 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $356,838 | 179,316 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $292,285 | 179,316 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $970,404 | 425,616 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $909,333 | 586,667 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,378,667 | 586,667 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,766,601 | 486,667 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,206,401 | 346,667 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,382,335 | 216,667 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,230,490 | 191,070 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,162,829 | 928,253 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,214,337 | 930,394 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,164,116 | 1,176,150 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,234,685 | 1,176,150 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,061,761 | 496,150 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,404,104 | 496,150 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,068,945 | 496,150 | Shares | Sole | 2022-05-16 | |
| 2020-06-30 | $1,029,687 | 64,235 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,316,602 | 219,800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||